These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29706026)

  • 1. Tripartite motif-containing proteins precisely and positively affect host antiviral immune response.
    Wei Y; Chen S; Wang M; Cheng A
    Scand J Immunol; 2018 Jun; 87(6):e12669. PubMed ID: 29706026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIMming Type I Interferon-Mediated Innate Immune Response in Antiviral and Antitumor Defense.
    Wang L; Ning S
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To TRIM or not to TRIM: the balance of host-virus interactions mediated by the ubiquitin system.
    Hage A; Rajsbaum R
    J Gen Virol; 2019 Dec; 100(12):1641-1662. PubMed ID: 31661051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VAMP8 Contributes to the TRIM6-Mediated Type I Interferon Antiviral Response during West Nile Virus Infection.
    van Tol S; Atkins C; Bharaj P; Johnson KN; Hage A; Freiberg AN; Rajsbaum R
    J Virol; 2020 Jan; 94(2):. PubMed ID: 31694946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity.
    Rajsbaum R; García-Sastre A; Versteeg GA
    J Mol Biol; 2014 Mar; 426(6):1265-84. PubMed ID: 24333484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Matrix Protein of Nipah Virus Targets the E3-Ubiquitin Ligase TRIM6 to Inhibit the IKKε Kinase-Mediated Type-I IFN Antiviral Response.
    Bharaj P; Wang YE; Dawes BE; Yun TE; Park A; Yen B; Basler CF; Freiberg AN; Lee B; Rajsbaum R
    PLoS Pathog; 2016 Sep; 12(9):e1005880. PubMed ID: 27622505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM proteins: another class of viral victims.
    Munir M
    Sci Signal; 2010 Apr; 3(118):jc2. PubMed ID: 20407122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Roles of TRIMs in Antiviral Innate Immune Signaling.
    Shen Z; Wei L; Yu ZB; Yao ZY; Cheng J; Wang YT; Song XT; Li M
    Front Cell Infect Microbiol; 2021; 11():628275. PubMed ID: 33791238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM Proteins and Their Roles in Antiviral Host Defenses.
    van Gent M; Sparrer KMJ; Gack MU
    Annu Rev Virol; 2018 Sep; 5(1):385-405. PubMed ID: 29949725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Mitochondria-Derived Immune Activation by 'Antiviral' TRIM Proteins.
    Oh S; Mandell MA
    Viruses; 2024 Jul; 16(7):. PubMed ID: 39066323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
    Cui J; Chen Y; Wang HY; Wang RF
    Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of feline tripartite motif-containing 25 interferes with the late stage of feline leukemia virus replication.
    Koba R; Oguma K; Sentsui H
    Virus Res; 2015 Jun; 204():88-94. PubMed ID: 25913257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C-Terminal Tail of TRIM56 Dictates Antiviral Restriction of Influenza A and B Viruses by Impeding Viral RNA Synthesis.
    Liu B; Li NL; Shen Y; Bao X; Fabrizio T; Elbahesh H; Webby RJ; Li K
    J Virol; 2016 May; 90(9):4369-4382. PubMed ID: 26889027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14-3-3 scaffold proteins mediate the inactivation of trim25 and inhibition of the type I interferon response by herpesvirus deconjugases.
    Gupta S; Ylä-Anttila P; Sandalova T; Sun R; Achour A; Masucci MG
    PLoS Pathog; 2019 Nov; 15(11):e1008146. PubMed ID: 31710640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How ISG15 combats viral infection.
    Freitas BT; Scholte FEM; Bergeron É; Pegan SD
    Virus Res; 2020 Sep; 286():198036. PubMed ID: 32492472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To TRIM the Immunity: From Innate to Adaptive Immunity.
    Yang W; Gu Z; Zhang H; Hu H
    Front Immunol; 2020; 11():02157. PubMed ID: 33117334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between Autophagy and Type I Interferon Responses in Innate Antiviral Immunity.
    Tian Y; Wang ML; Zhao J
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30717138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular Antiviral Immunity.
    Bottermann M; James LC
    Adv Virus Res; 2018; 100():309-354. PubMed ID: 29551141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlapping and distinct molecular determinants dictating the antiviral activities of TRIM56 against flaviviruses and coronavirus.
    Liu B; Li NL; Wang J; Shi PY; Wang T; Miller MA; Li K
    J Virol; 2014 Dec; 88(23):13821-35. PubMed ID: 25253338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 27, Similar to Interferons, Modulates Gene Expression of Tripartite Motif (TRIM) Family Members and Interferes with Mayaro Virus Replication in Human Macrophages.
    Hernández-Sarmiento LJ; Tamayo-Molina YS; Valdés-López JF; Urcuqui-Inchima S
    Viruses; 2024 Jun; 16(6):. PubMed ID: 38932287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.